AXOVANT GENE THERAPIES LTD's ticker is and the CUSIP is G0750W903. A total of 3 filers reported holding AXOVANT GENE THERAPIES LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $191,000 | +4675.0% | 417 | +2216.7% | 0.00% | – |
| Q2 2020 | $4,000 | +100.0% | 18 | +12.5% | 0.00% | – |
| Q1 2020 | $2,000 | -99.5% | 16 | -98.0% | 0.00% | -100.0% |
| Q4 2019 | $401,000 | -11.3% | 785 | +12.0% | 0.00% | 0.0% |
| Q3 2019 | $452,000 | -61.1% | 701 | -62.5% | 0.00% | -66.7% |
| Q2 2019 | $1,163,000 | – | 1,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 27,600 | $128,000 | 0.00% |
| SIMPLEX TRADING, LLC | 417 | $191,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |